|Articles|September 29, 2021
LEO Pharma and Veeva Systems Partner for Patient-centric Digital Trials
Advertisement
LEO Pharma and Veeva Systems have announced a strategic technology partnership to enable scalable digital trials that are patient-centric and paperless. LEO Pharma will utilize the integrated suite of Veeva clinical products, including eTMF, CTMS, CDMS, Site Connect, eConsent, ePRO, Virtual Visits, and eSource.
By adopting technology and business processes, LEO Pharma hopes to achieve the following:
- Significantly improved patient experience
- Increased patient diversity through decentralized trials
- Higher accuracy in clinical data
- 25% reduction in clinical trial cost
- 25% reduction in clinical trial time
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program
2
Beyond Compliance: ProofPilot's Joseph Kim and Lauren Briggs on Making Clinical Trial Training Actually Work
3
ACT Brief: Efficacy Ceiling Breakthrough in Autoimmune Disease, Early-Career Retention and Burnout Prevention, and PRV Program Catalyzing Rare Disease Investment
4
Breaking the Efficacy Ceiling in IBD and Beyond
5